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We read with interest the report of Dr Kim and colleagues, enti-
tled “Diagnostic utility of three-dimensional power Doppler ultra-
sound for postmenopausal bleeding,” which was published in the
June issue of the Taiwanese Journal of Obstetrics and Gynecology
(TJOG) this year [1]. The authors performed a prospective observa-
tional study between 2009 and 2012 to investigate 225 women
complaining of postmenopausal bleeding. Results showed that
endometrial thickness, endometrial volume, vascularization index,
ﬂow index, and vascularization ﬂow index could be used to distin-
guish the benign from the malignant endometrial lesion; in addi-
tion, endometrial thickness and vascularization ﬂow index could
be further used to distinguish other benign from hyperplasia endo-
metrial lesions. The authors concluded that the diagnostic useful-
ness of three-dimensional power Doppler ultrasound for
endometrial thickness is promising in women with postmeno-
pausal endometrial bleeding. Although the study was well
designed, some questions are raised about this article. We hope
that the authors would respond to our questions.
First, the authors might have made a typing error on page 223 of
TJOG [1]. The phrase “the best predictive values were 7.5 mm for
endometrial thickness and 2.275 for VFI” should be used in place
of the original form the authors wroted“the best predictive values
were 7.5 mm for endometrial volume and 2.275 for VFI” [1].
Second, we are wondering why the endometrial thickness of
women in the benign group was higher up to 8.70 mm of the
mean (3.91 mm of the standard deviation)? If the mean thickness
of the endometrium in the benign group was near 9 mm, it is not
practical to use an endometrial thickness of 9.5 mm as a cutoff
value to predict endometrial malignancy. The difference used to
distinguish the benign from malignancy should be large enough
to avoid bias of interoperators and intraoperators. We believe
that this thickness might be overestimated, and it is possible that
the authors enrolled women with endometrial polyp and/or endo-
metrial hyperplasia into the benign group, which might signiﬁ-
cantly increase the estimate of the thickness of the endometrium.
Therefore, could the authors provide the mean and standard
deviation of the endometrial thickness after excluding endometrial
polyp, endometrial hyperplasia, and endometrial cancers? InDOI of original article: http://dx.doi.org/10.1016/j.tjog.2013.10.043.
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).addition, the classiﬁcation of the endometrial hyperplasia could
be found in everywhere [2,3], but the clinical signiﬁcance might
be much different. It is sometimes difﬁcult to distinguish complex
hyperplasia with atypia from cancer, suggesting that the authors
should separate these lesions clearly, and re-analysis of their data
is welcome.
Third, in terms of endometrial vascularization ﬂow index, a
similar argument was raised. The mean of endometrial vasculariza-
tion ﬂow index was 2.77 with a standard deviation of 2.23 in the
benign group, however, the authors suggested that the cutoff value
of the vascularization ﬂow index was 3.765 and 2.275 to predict the
endometrial malignancy and endometrial hyperplasia, respectively
[1]. The overlapping range between the benign and malignancy
might impede the value for clinical practice.
Our comments are not intended to dispute the excellent work of
Dr Kim and colleagues. We made our comments, because we
believe that better techniques and higher resolution of the transva-
ginal ultrasound as well as careful history taking are still the gold
standard to investigate women with postmenopausal bleeding.
Although many high-technology advances, such as that suggested
by the authors (three-dimensional power Doppler ultrasound),
will provide additional value to improve the diagnostic accuracy
of various diseases (e.g., Dr Kim's report), and all are welcome,
any beneﬁt should be balanced with the expense, that is to say
that cost-effectiveness should always be taken into consideration.
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